DE19975044I2 - Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten - Google Patents

Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten

Info

Publication number
DE19975044I2
DE19975044I2 DE1999175044 DE19975044C DE19975044I2 DE 19975044 I2 DE19975044 I2 DE 19975044I2 DE 1999175044 DE1999175044 DE 1999175044 DE 19975044 C DE19975044 C DE 19975044C DE 19975044 I2 DE19975044 I2 DE 19975044I2
Authority
DE
Germany
Prior art keywords
adenosine
intravenous infusion
continuous intravenous
medicament
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1999175044
Other languages
English (en)
Inventor
Alf Sollevi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Item Development AB
Original Assignee
Item Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25116698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE19975044(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Item Development AB filed Critical Item Development AB
Application granted granted Critical
Publication of DE19975044I2 publication Critical patent/DE19975044I2/de
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE1999175044 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten Active DE19975044I2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77951685A 1985-09-24 1985-09-24

Publications (1)

Publication Number Publication Date
DE19975044I2 true DE19975044I2 (de) 2006-02-02

Family

ID=25116698

Family Applications (4)

Application Number Title Priority Date Filing Date
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
DE19853590855 Withdrawn DE3590855T1 (de) 1985-09-24 1985-10-29
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.
DE1999175044 Active DE19975044I2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten

Family Applications Before (3)

Application Number Title Priority Date Filing Date
DE3588205T Expired - Lifetime DE3588205T2 (de) 1985-09-24 1985-10-29 Verwendung von Adenosin zur Herstellung eines Arzneimittels für kontinuierliche Intravenöse Infusion an menschlichen Patienten
DE19853590855 Withdrawn DE3590855T1 (de) 1985-09-24 1985-10-29
DE3586993T Expired - Fee Related DE3586993T3 (de) 1985-09-24 1985-10-29 Kontinuierliche intravenöse infusion von adenosin an menschlichen patienten, einheitsdosierungsform von adenosin und dessen verwendung bei der herstellung von arzneimitteln.

Country Status (9)

Country Link
EP (2) EP0506205B1 (de)
JP (1) JP2535504B2 (de)
AT (2) ATE84419T1 (de)
AU (1) AU613304B2 (de)
CA (1) CA1301652C (de)
DE (4) DE3588205T2 (de)
DK (1) DK253187D0 (de)
NZ (1) NZ217592A (de)
WO (1) WO1987001593A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618723B2 (en) * 1986-10-06 1992-01-09 University Of Virginia Alumni Patents Foundation, The Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US6004945A (en) 1990-05-10 1999-12-21 Fukunaga; Atsuo F. Use of adenosine compounds to relieve pain
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5256398A (en) * 1990-11-08 1993-10-26 Whitby Research, Inc. Composition for determining viability of tissue
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method
US20130288370A1 (en) 2010-10-15 2013-10-31 Cytopherx, Inc. Cytopheresis cartridges and use thereof
US20140350553A1 (en) * 2011-11-21 2014-11-27 Denerve Inc. Renal artery ablation catheter and system
CA2860831A1 (en) 2012-01-09 2013-07-18 H. David Humes Cartridge and method for increasing myocardial function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845205A (en) * 1970-06-04 1974-10-29 Univ Sydney 2-loweralkylthioadenosines
FR2129833B1 (de) * 1971-03-16 1974-08-02 Cerm Cent Europ Rech Mauvernay
ZA7469B (en) * 1973-01-16 1974-11-27 J Voorhees Compositions and treatment of proliferative skin diseases with-c-amp analogs
DE3133925A1 (de) * 1981-08-27 1983-03-17 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittel zur behandlung von hypertonie
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten

Also Published As

Publication number Publication date
DE3586993T3 (de) 1998-03-19
ATE84419T1 (de) 1993-01-15
JP2535504B2 (ja) 1996-09-18
EP0506205B1 (de) 1999-01-27
DE3588205D1 (de) 1999-03-11
AU5065585A (en) 1987-04-07
NZ217592A (en) 1990-10-26
DE3590855T1 (de) 1988-08-25
AU613304B2 (en) 1991-08-01
CA1301652C (en) 1992-05-26
EP0275249B1 (de) 1993-01-13
DE3586993D1 (de) 1993-02-25
DE3586993T2 (de) 1993-04-29
DK253187A (da) 1987-05-19
DK253187D0 (da) 1987-05-19
EP0275249A1 (de) 1988-07-27
WO1987001593A1 (en) 1987-03-26
DE3588205T2 (de) 1999-06-02
JPS63501497A (ja) 1988-06-09
ATE176154T1 (de) 1999-02-15
EP0506205A1 (de) 1992-09-30
EP0275249B2 (de) 1997-12-17

Similar Documents

Publication Publication Date Title
DE3662968D1 (en) Coronary perfusion pump
NO167203C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazinyl-derivater av puriner.
SE8506029D0 (sv) Hjert-lungsystem avsett for syresettning av en patients blod
DE352477T1 (de) Antikrebswirkungen in einem organismus, durch erhoehen der blut- und plasmawerte von adenosin-5'-triphosphat (atp).
NO175023C (no) Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering
DE19975044I2 (de) Verwendung von Adenosin zur Herstellung eines Arzneimittels f}r kontinuierliche Intraven¦se Infusionan menschlichen Patienten
Freyschuss et al. Circulatory adaptation to one-and two-leg exercise in supine position.
Boarini et al. Comparison of systemic and cerebrovascular effects of isoflurane and halothane
ZA874198B (en) D-fenfluramine for use in the treatment of depression
Kontos et al. Circulatory responses to hypocapnia in the anesthetized dog
Neill et al. Acute and chronic cardiovascular adjustments to induced anemia in dogs
DK63488A (da) Anvendelse af human blod-koagulationsfaktor xiii til behandling af ulcerativ colitis
Moreno The therapeutic role of the blues singer and considerations for the clinical applications of the blues form.
Szatmary et al. Haemodynamic and antiischaemic protective effects of intra-aortic balloon counterpulsation in high risk coronary heart patients undergoing percutaneous transluminal coronary angioplasty
Davis et al. Comparison of changes in blood volume and opacity in dog digital pad and tongue.
ATE86105T1 (de) Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie.
Abrahams Intramuscular heparin
DE3876425D1 (de) Gesteuerte verabreichung eines heilmittels an blut.
FRANKL et al. The effects of smoking on the cardiac output at rest and during exercise in patients with healed myocardial infarction
Smith The coronary circulation
Slósarska et al. Physiological reactivity of patients with endogenous and neurotic depression.
Jørstad et al. Intraarterial Blood Pressure Measurements During Electro Shock Convulsive Treatment with and Without a Muscle Relaxant (Succinylcholin Iodide)
MESHALKIN et al. Unsteady blood flow in humans under artificial conditions((Russian book))(Nestatsionarnyi krovotok u cheloveka v iskusstvennykh usloviiakh)
Sadick et al. Hyperemic response to coronary occlusion during a single diastole in conscious dog
Luchik Ophthalmodynamometric and Ophthalmoscopic Examinations in Patients with Transient Disorders of Cerebral Blood Circulation